IQV vs OGEN · P/E 23, rev $15.40B vs rev $37.7K
IQVIA Holdings Inc (IQV) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
IQVIA Holdings Inc (IQV) is a diagnostics & research company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported IQV revenue for 2024-12-31 was $15.40B. Net income was $1.37B. Revenue was up 2.8% from 2023-12-31 to 2024-12-31. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
IQV currently screens at market cap $30.62B and trailing P/E 22.8. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the IQV and OGEN stock pages for the full models.
Not investment advice.